Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Sorrento Therapeutics, Inc. (OTC: SRNEQ) announced on April 25, 2023, that the U.S. Bankruptcy Court for the Southern District of Texas extended the restrictions on the transfer of shares for Scilex Holding Company, distributed as a dividend on January 19, 2023. This extension defers the selling, transferring, or disposing of these distributed shares from May 11, 2023, to September 1, 2023. The restrictions apply solely to the Distributed Stock and do not affect other Scilex securities held by Sorrento. Sorrento is focused on developing therapies for cancer, pain, and infectious diseases and has ongoing clinical trials for several novel products.